ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,732Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 274

$1.04M Total Retail Price of All Prescriptions

Rank: 18 out of 274

1,090 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,090 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

3% of this provider’s 1,090 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 9,757 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

51% of this provider’s prescriptions were for brand-name drugs, compared to an average of 50%.

Prescription Price

$97 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 2,206 2,031 1 1
NOVOLOG MIX 70-30 605 552 10 2 31
METFORMIN HCL 404 336 3 3
JANUMET 372 325 4 22
NOVOLOG 348 303 5 13
INSULIN SYRINGE 284 248 6 9
EASY TOUCH 271 247 10 7 98
JANUVIA 259 234 8 10
LEVEMIR 251 242 9 39
GLYBURIDE-METFORMIN HCL 248 185 R 10 40
SYNTHROID 240 233 11 2
ATELVIA 229 215 12 120
SIMVASTATIN 206 181 13 8
CRESTOR 178 149 14 17
SURE COMFORT 176 156 15 49
GLIMEPIRIDE 168 164 16 5
NOVOLOG MIX 70-30 FLEXPEN 143 140 17 25
NOVOLOG FLEXPEN 141 117 18 12
PEN NEEDLE 126 108 19 4
LISINOPRIL 115 114 20 14
LANTUS 103 84 21 7
PANTOPRAZOLE SODIUM 99 99 22 103
ONGLYZA 94 89 23 33
LOSARTAN POTASSIUM 94 85 23 28
GABAPENTIN 93 83 25 30
PLAVIX 92 92 26 75
ACTOS 82 76 27 29
METHIMAZOLE 78 78 28 19
AMLODIPINE BESYLATE 78 77 28 21
BYDUREON 75 65 30 95
CARVEDILOL 75 74 30 45
CLOPIDOGREL 71 62 32 68
LEVEMIR FLEXPEN 68 63 33 23
NOVOFINE 32 66 65 34 55
ATORVASTATIN CALCIUM 63 61 35 20
METOPROLOL SUCCINATE 53 52 36 51
SENSIPAR 53 53 36 131
LANTUS SOLOSTAR 53 34 36 6
ALPRAZOLAM 51 51 39 116
CABERGOLINE 50 42 40 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.